It’s A huge Landmark Achievement For Nigeria As WHO Grants Pre-Qualification CDCL To NAFDAC- Pro.Adeyeye.

 National Agency for Food and Drug Administration and Control (NAFDAC) has delighted to announce a momentous achievement of the Central Drug Control Laboratory (CDCL) in Yaba, Lagos State, Nigeria by the World Health Organization (WHO) saying that it’s a huge Landmark Achievement For the agency and entire Nigerian.

The NAFDAC acknowledged that the officially granted WHO Prequalification Status to the CDCL, signifying a milestone in its dedication to ensuring the safety and quality of pharmaceutical products in Nigeria.

Speaking on the development, the Director General ( DG) Professor, Mojisola Adeyeye, said that this was communicated to them through a mail received from WHO Prequalification Inspection team on Friday 15th September, 2023 and the success was finally published on the WHO website last week and the website address through which the public can cite and reference this was shared with us to for dissemination to the general public.

She said that the agency is a Nigeria's regulatory body responsible for ensuring the safety and quality of food, drugs, cosmetics, medical devices, and other related products and its mission is to safeguard public health by ensuring that only safe and wholesome products are made available to the Nigerian populace.

According to her, this is a huge landmark achievement for the Agency and Nigeria. Very few laboratories in the world have the apex status of WHO Prequalification.

“Our journey towards this milestone actually started since year 2010, but with renewed efforts and more commitment to attempts by our management and Federal Government in the last Four years, we have finally achieved this goal”

“The WHO Prequalification of the CDCL is a testament to the unwavering commitment of NAFDAC to meeting international standards of excellence in drug quality control and regulation.”

“This prestigious recognition brings numerous benefits to CDCL, NAFDAC, and, most importantly, to the Nigerian people” Adeyeye said.

She further stated that the Key benefits of the WHO Prequalification of NAFDAC CDCL includes global Recognition; Enhanced Pharmaceutical Quality International Collaboration and many more .

She added that this achievement would not have been possible without the hard work, dedication, and unwavering commitment of the Honourable Minister of Health, NAFDAC management, CDCL staff, NAFDAC management, our esteemed partners such as WHO Nigeria Country Office, USP PQM+ Nigeria Country office and Global Fund,

“It underscores our commitment to safeguarding public health and improving healthcare access for all Nigerians”.

“We are excited about the possibilities that this recognition brings and look forward to continuing our work to uphold the highest standards of pharmaceutical quality control and regulation”

“ NAFDAC remains committed to its mission of safeguarding public health by ensuring that only safe, effective, and quality medicines and healthcare products are available to all Nigerians” she said